Center for Biomedical Research, Inc. Report issue

For profit Phase 1
Founded: Boise ID United States (2002)

Organization Overview

First Clinical Trial
2018
NCT04279535
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

CBR,Inc. | Center for Biomedical Research, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

vitamin c (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 1)

Carcinoma, Basal Cell (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1